Skip to main content
VCbacked
Log inGet Started

Credence MedSystems

Menlo Park, United States

Credence MedSystems is a drug delivery and specialty pharmaceutical company focused on delivering medications safely.

$12.7M raised
Dec 2024
Venture - Series Unknown
BiopharmaBiotechnologyHealth CareManufacturingPharmaceutical

Top Investors

Bill & Melinda Gates FoundationNovartisMaverick VenturesMolex Ventures

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Credence MedSystems

How much funding has Credence MedSystems raised?
Credence MedSystems has raised $12.7M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in December 2024.
Who are Credence MedSystems's investors?
Credence MedSystems's investors include Bill & Melinda Gates Foundation, Novartis, Maverick Ventures, Molex Ventures.
Where is Credence MedSystems headquartered?
Credence MedSystems is headquartered in Menlo Park, United States.
What does Credence MedSystems do?
Credence MedSystems is a drug delivery and specialty pharmaceutical company focused on delivering medications safely.
What stage is Credence MedSystems at?
Credence MedSystems is at the Venture - Series Unknown stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Credence MedSystems — Funding & Investors." VCBacked, December 30, 2024, https://www.vcbacked.co/company/credence-medsystems. Accessed June 4, 2026.
APA
VCBacked. (2024). Credence MedSystems — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/credence-medsystems
Wikipedia (cite web)
{{cite web |title=Credence MedSystems — Funding & Investors |url=https://www.vcbacked.co/company/credence-medsystems |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biopharma

View all
ParcelBio
San Francisco$13.2M
Modicus Prime
Austin
Latus Bio
Philadelphia
Ocugen
Malvern
Ember LifeSciences
Los Angeles$16.5M
ClearNote Health
San Diego